myStudy is an AI-native clinical trial technology platform founded by Matt, the former co-founder of Healthforge and COO of Beckley Psytech. The company is building modern replacements for legacy software, starting with recruitment and screening tools for a global Phase 3 pharmaceutical programme in treatment-resistant depression.
